
In Kaposi sarcoma, cancerous cells are detected in the skin lining the gastrointestinal (GI) system, which includes the stomach and intestines and expands from the mouth to the anus.
These tumours can migrate to lymph nodes and the lungs and manifest as purple patches or nodules on the skin and mucous membranes. Patients with weakened immune systems and men are more likely to develop Kaposi sarcoma.
There are many types of Kaposi Sarcoma-
Timely treatment of Kaposi Sarcoma is vital for many reasons since it may significantly affect the patient's general health and the course of the illness.
Human herpesvirus 8 (HHV-8) infection is the primary cause of KS. However, the chance of having KS is increased by several risk factors.
Stem cell therapy is being investigated as a possible treatment for KS, especially for patients with severe immunosuppression. However, it is still in the experimental stage. Fighting cancer may aid in immune cell regeneration and restoring normal immunological function. Many emerging therapies are being explored, like immunotherapies and molecular diagnostics, that are still undergoing clinical trials to improve patient outcomes, particularly for patients with compromised immune systems, such as those living with AIDS/HIV.
These developments provide more effective, individualised treatment plans, improving patients' quality of life and survival rates.
Maintaining a healthy immune system and lowering the chance of infection with the Kaposi sarcoma-associated herpesvirus (KSHV) are two ways to prevent Kaposi sarcoma (KS). Here are some tips:
Treatment options for Kaposi sarcoma (KS) differ based on the type and stage of the disease and the patient's overall health. The following are a few current treatments:
Radiation Therapy: Treatments using high-energy rays to shrink and control KS lesions. Specifically targeting localised lesions.
Chemotherapy : KS may be treated with conventional chemotherapy medications, although these are less frequently utilised than immunotherapy or targeted therapy. Chemotherapy kills cancer cells that divide quickly and can be given orally or intravenously.
Cost Start From USD 600 - USD 700Explore Options
Immunotherapy : Immunotherapy boosts your immune system to help fight KS.
Cost Start From USD 3000 - USD 5000Explore Options
Clinical Evaluation
Imaging Studies
Biopsy
MediRehab (chain of Rehab centres - Part of MediGence) that provides comprehensive rehabilitation services designed to support KS patients in India. These services include:
MediGence can assist and guide you in selecting the best physician and medical facility for your care.
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.









Mumbai, India
Seven Hills Hospital located in Mumbai, India is accredited by JCI, NABH, NABL. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Many factors, such as the patient's immunological state, stage of the disease, and whether they have HIV/AIDS or other underlying disorders, affect how long a person with Kaposi Sarcoma (KS) will live.
Early therapy for localised KS improves prognosis; many patients experience remission. A more dire prognosis could result, though, if KS affects internal organs or is discovered at an advanced stage.
The stage of diagnosis, the type of treatment, and the unique characteristics of each patient all affect the success rate of Kaposi sarcoma (KS) treatment in India.
Many patients get remission in early-stage KS, which typically has a fairly high success rate. The success rate for advanced-stage KS may be lower, but results are getting better.
In India, Kaposi Sarcoma (KS) is not regarded as a common cancers as compared to other types of cancers like breast, lungs, gastrointestinal cancers. It is an uncommon type of cancer that mostly affects people who have HIV/AIDS or who are immunocompromised as a result of medical procedures like organ transplants.
The rate at which Kaposi Sarcoma (KS) spreads varies based on the type and immune system of the patient. KS can spread quickly from the skin to internal organs such the liver, lungs, or gastrointestinal system in individuals with HIV/AIDS or immunocompromised diseases.
The illness usually stays restricted to the skin and advances slowly in older people without HIV who have classic KS.
Kaposi Sarcoma (KS) is frequently treatable and controllable, however, it may not permanently be cured, mainly if it is advanced.
The patient's immunological state, whether they are HIV-positive or receiving immunosuppressive treatment, and the disease's stage all affect the prognosis for Kaposi Sarcoma (KS) in India.
Strengthening the immune system and halting the disease's progress can greatly improve the prognosis for individuals with HIV.
Chemotherapy, radiation therapy, or surgery may result in remission if KS is localised to the skin. The prognosis worsens, though, when internal organs are impacted. In general, greater results can be obtained in India by early detection and prompt treatment, particularly for those with strong immune systems.
In India, recovery times following Kaposi sarcoma (KS) surgery can differ depending on the procedure's scope and personal circumstances. Recovery from localised KS typically takes a few weeks. Recovery could take longer, possibly several months, if lymph nodes are affected and further surgery or radiation therapy is needed.